Choice of stent in iliac occlusive disease

Percutaneous transluminal angioplasty has become widely spread as the initial treatment in patients with iliac occlusive disease. Although not confirmed by the current TransAtlantic Inter-Society Consensus (TASC) II recommendations, endovascular repair of complex aortoiliac lesions is feasible and gives similar angiographic and clinical outcome compared with open surgery at both shortand long-term follow-up, even in complex lesion configurations. Besides the commonly accepted TASC A and B lesions, TASC C and D lesions could also be treated endovasculary with the current devices, techniques and modalities. This opens new perspectives for a group of patients presenting with severe comorbidities.